Oli’s communications journey started as part of an international research group, creating and implementing global materials aiming to improve the understanding of health and, ultimately, the treatment of patients.
Working in med comms he has built on this, delivering multi-channel med ed programmes with the impact on patients being the driving force. Oli has worked across global and regional accounts for therapeutic areas spanning rheumatology, oncology, neurology, nutrition and diabetes. From key message development during Phase III trials, to congress activities for established medicines, he has experience of activities throughout all elements of a brand’s lifecycle and a personal drive to utilise digital channels wherever possible.